Fermentation, that ancient alchemy of microbes and sugar, is undergoing a metamorphosis. For thousands of years, it served humanity as a way to make bread rise, beer bubble, and soybeans sing into miso. But in the 21st century, fermentation has broken free of the kitchen and brewery to become one of the most powerful tools […]
Cytokines sit at the crossroads of immunology, biotechnology, and therapeutic innovation. They are signaling proteins with outsized influence: modulating immune responses, orchestrating cellular communication, and increasingly becoming the backbone of modern biologics. For Contract Development and Manufacturing Organizations (CDMOs), cytokines represent both an opportunity and a challenge. They promise lucrative markets in regenerative medicine, oncology, […]
Introduction: The Strange Mirror of Biopharma and Food Biopharma has long viewed itself as the high temple of fermentation. From the earliest recombinant insulin made in E. coli to monoclonal antibodies expressed in CHO cells, the industry has prided itself on scientific rigor, regulatory discipline, and painstaking optimization. Each bioreactor is treated like a cathedral of sterility […]
Introduction: Why “Beyond E. coli” Matters For decades, E. coli has been the undisputed workhorse of microbial biomanufacturing. From recombinant insulin in the 1980s to a vast array of enzymes, antibody fragments, and research proteins, E. coli has set the standard for scalability, cost efficiency, and genetic tractability. Yet as the biologics landscape becomes increasingly complex—spanning full-length antibodies, […]
Among microbial expression hosts, Bacillus has carved out a unique niche in biomanufacturing. Unlike Gram-negative bacteria such as E. coli, Bacillus subtilis and related species are naturally endotoxin-free, simplifying downstream purification and expanding their appeal for therapeutic proteins, enzymes, and next-generation biologics. For a Contract Development and Manufacturing Organization (CDMO), mastery of Bacillus systems requires balancing its advantages—secretion capability, GRAS status, industrial […]
Endotoxin removal is one of the most persistent bottlenecks in bringing therapeutic bacteriophages to market. Produced by the outer membrane of Gram-negative bacteria, endotoxins (lipopolysaccharides, or LPS) can trigger severe immune reactions in patients if not reduced to ultra-low levels. For a Contract Development and Manufacturing Organization (CDMO), especially one producing phage therapies at GMP […]
Pseudomonas phages—viruses that specifically infect and destroy Pseudomonas aeruginosa—are emerging as a leading tool in the fight against multi-drug resistant (MDR) bacteria. This opportunistic pathogen is a notorious cause of chronic lung infections in cystic fibrosis patients, life-threatening burn wound infections, and stubborn hospital-acquired infections. Unlike traditional antibiotics, a well-characterized Pseudomonas phage can selectively target pathogenic P. aeruginosa strains while […]
Protein fermentation has rapidly evolved from a niche laboratory practice into a cornerstone of sustainable biotechnology. Fueled by breakthroughs in synthetic biology, novel bioreactor designs, and AI-driven process control, today’s protein fermentation platforms promise to reshape food, pharmaceuticals, and beyond. This post explores the latest scientific developments, newsworthy milestones, and emerging trends driving the field […]
Bacteriophages—viruses that infect and kill bacteria—are experiencing a renaissance as powerful tools in the fight against antibiotic resistance, as well as innovators in microbiome engineering and probiotic enhancement. Once relegated to niche academic interest, phages now promise precision antibacterials that leave beneficial microbes intact, live biotherapeutic products that modulate our gut ecosystems, and bio-control agents […]
The microbial CDMO space is more competitive than ever. With Pichia (now Komagataella phaffii) gaining traction as a powerful expression system, contract development and manufacturing organizations (CDMOs) must sharpen their gameplan. Here are the top ten traits that separate a great Pichia CDMO from the rest—and a few extras to elevate performance across microbial and yeast-based […]